Viral Vectors for Gene Therapy | Revvity

US

Search all

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Republic of Korea *

Viral vector - hero

Viral vectors are highly efficient vehicles for gene delivery into a specific cell type or tissue for an array of research purposes.

Our viral vector technologies and services have empowered innovators in cell therapy, gene therapy, and vaccination to successfully advance their therapies from preclinical research through development and ultimately to market.

How Revvity can support you

Regardless of the field of application, viral vector-based therapies go through a discovery phase where proof-of-concept is established, vectors are optimized, and safety and efficiency studies of the lead vector candidate are completed.

Revvity's gene delivery team, where SIRION Biotech’s expertise lives on, has deep know-how in viral vector development and manufacturing with 20 years of experience in the field. We offer a comprehensive viral vector offering, covering adeno-associated viruses (AAVs), lentiviruses (LV) and Adenoviruses (AVs) for early discovery and preclinical research stages.

Our gene delivery portfolio includes:

Viral vector development and manufacturing services - leverage our team’s deep experience and advanced technology to help accelerate the process and find the right balance of flexibility, scalability, and quality for your viral vectors.
LentiBOOST™ lentiviral transduction enhancer provides improved transduction efficiency to help reduce manufacturing costs and improve the effectiveness of your cell therapy.
AAV capsid evolution and nanobody targeting technologies and services which can deliver improved performance from your AAV vectors.
A range of viral vector technologies across AAV, LV and AV platforms to help improve vector efficacy, quality, and yields.

Explore our gene delivery portfolio

adenovirus

Adenovirus

Adenoviral vectors offer high levels of transgene expression in broad cell types, including dividing and non-dividing cells.

AAV Green_512x288

AAV Capsid Development

Revvity’s gene delivery team, where SIRION Biotech’s expertise lives on, has been partnering with pharma and biotech organizations for many years to provide improved viral vectors using our AAV capabilities.

lentivirus

Lentivirus

Lentiviruses are a subtype of retroviruses which have a single stranded RNA genome that encode for three major structural genes: gag, pol, and env.

LentiBOOST-TransductionEnhancer512x288

LentiBOOST™ Technology

LentiBOOST is a highly effective, non-cytotoxic transduction enhancer for clinical application of lentiviral vectors in a wide range of cell types.

ad19a adenoviral vector manufacturing hero

Ad19a/64 Adenoviral Vector

Our proprietary Ad19a/64 vector (Subtype D) can be used to overcome the low transduction efficiency of commonly used Ad serotypes and help overcome the challenge of pre-existing immunity against commonly used adenovirus serotypes.

View all View less

You may also be interested in

GeneDeliveryLicensing-512x288

Gene Delivery Licensing

Revvity Gene Delivery has developed a global CDMO network over the last 5 years and can recommend and introduce CDMOs worldwide that best suit customer location and individual project requirements.

Viral-vector-manufacture-services512x288

Viral Vector Engineering and Manufacture

Individualized and customized solutions tailored to fit viral vector projects at all stages of discovery and development, ensuring fast and cost-effective product manufacture.

View all View less

For research use only. Not for use in diagnostic procedures.

LentiBOOST Pharma-Grade: For research use only. Not for use in diagnostic procedures.

LentiBOOST GMP Grade: Not for diagnostic use. Other applications must be authorized by a license from Revvity.

line

How can we help you?

We are here to answer your questions.

I need assistance with purchase

I need assistance with purchase

Request technical support

Request technical support